Beta-adrenergic antagonists are one of the most commonly used class of agents in the treatment of hypertension. They have also demonstrated utility in the treatment of angina pectoris and certain arrhythmias and for the reduction in mortality following a myocardial infarction. The use of this class of agents creates the potential for beta-blocker exposure among lactating women. This review focuses on the most up-to-date data regarding the more common agents—metoprolol, atenolol, propranolol, carvedilol, nadolol, sotalol, and betaxolol—and their safety in lactating women.
Fox RE, et al. Neonatal effects of maternal nadolol therapy. Am J Obstet Gynecol. 1985;152:1045-1046.
3.
Lip GY, et al. Effect of atenolol on birth weight. Am J Cardiol. 1997;79: 1436-1438.
4.
Liedholm H, Melander A, Bitzen PO, et al. Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol. 1981;20: 229-231.
5.
Kulas J, Lunell NO, Rosing U, et al. Atenolol and metoprolol: A comparison of their excretion into human breast milk. Acta Obstet Gynecol Scand Suppl. 1984;118:65-69.
6.
Sandstrom B, Lindeberg S, Lundborg P, et al. Disposition of the adrenergic blocker metoprolol in the late pregnant women, the amniotic fluid, the cord blood and the neonate. Clin Exp Hypertens1983;B2: 75-82.
7.
Sandstrom B.Metoprolol excretion into breast milk. Br J Clin Pharmacol. 1980;9:518-519.
8.
Sandstrom B.Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest.1978;9: 195-204.
9.
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and chemicals into human milk. Pediatrics.1994;93:137-150.
10.
Fowler MB, Brudenell M, Jackson G, et al. Essential hypertension and pregnancy: Successful outcome with atenolol. Br J Clin Pract. 1984; 38:73-74.
11.
Thorley KJ, McAinsh J.Levels of the beta blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharm Drug Dispos. 1983;4:299-301.
12.
White WB, Andreoli JW, Wong SH, et al. Atenolol in human plasma and breast milk. Obstet Gynecol.1984;63:42S-44S.
13.
Lideholm H.Transplacental passage and breast milk accumulation of atenolol in humans. Drugs.1983;25(suppl 2):217-218.
14.
Schimmel MS, Eidelman AJ, Wilschanski MA, et al. Toxic effects of atenolol consumed during breast feeding. J Pediatr. 1989;114:476-478.
15.
Briggs GG, Freeman RK, Yaffe SJ.Drugs in pregnancy and lactation. 5th ed.Baltimore, Md: Williams & Wilkins; 1998.
16.
Bauer JH, Pape B, Zajicek J, et al. Propranolol in human plasma and breast milk. Am J Cardiol.1979; 43:860-862.
17.
Thorley KJ. Pharmacokinetics of atenolol in pregnancy and lactation. Drugs. 1983;25(suppl 2):216-217.
18.
Taylor EA, Turner P.Anti-hypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J. 1981;57:427-430.
19.
Levitan AA, Manion JC. Propranolol therapy during pregnancy and lactation. Am J Cardiol. 1973;32:247-247.
20.
Livingstone I, Craswell PW, Bevan EB. Propranolol in pregnancy: Three year prospective study. Clin Exp Hypertens. 1983;B2:341-350.
21.
Smith MT, Livingstone I, Hooper WD, et al. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma. Ther Drug Monit. 1983;5:87-93.
Devlin RG, Duchin KL, Fleiss PM. Nadolol in human serum and breast milk. Br J Clin Pharmcol. 1981;12:393-396.
24.
Fox RE, Marx C, Stark AR. Neonatal effects of maternal nadolol therapy. Am J Obstet Gynecol. 1985;152:1045-1046.
25.
O'Hare MF, Murnaghan GA, Russell CJ, et al. Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol. 1980;87:814-820.
26.
Hackett LP, Wojnar-Horton RE, Dusci LJ, et al. Excretion of sotalol in breast milk. Br J Clin Pharmacol. 1990;29:277-278.
27.
Wagner X, Jouglard J, Moulin M, et al. Coadministration of flecainide acetate and sotalol during pregnancy: Lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J. 1990;119:700-702.
28.
Morselli PL, Boutroy MJ, Bianchetti G, et al. Placental transfer and perinatal pharmacokinetics of betaxolol. Eur J Clin Pharmacol. 1990;38: 477-483.
